 |
|
Primary Prevention of Postmenopausal Osteoporosis
Wendy Levinson, MD;
Diane Altkorn, MD
JAMA. 1998;280:1821-1822.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
INTRODUCTION
MORE THAN 1 million osteoporosis-related fractures occur in the United States each year, resulting in estimated total expenditures exceeding $13 billion.1-2 Osteoporotic fractures, especially those of the hip, may be associated with a decline in functional status and quality of life and decreased survival.1 Both men and women lose bone at a rate of 0.3% to 0.5% per year beginning in the fourth decade, but at menopause, women experience accelerated bone loss at a rate of 3% to 5% per year for 5 to 7 years.3 Weight-bearing exercise may retard bone loss in postmenopausal women; since exercise also reduces the risk of cardiovascular disease and may reduce falls, advising healthy postmenopausal women to exercise is widely accepted. However, there is more controversy about what medications or supplements should be prescribed for osteoporosis prevention in healthy postmenopausal women. In this article, we review recent evidence . . . [Full Text of this Article]
Calcium and Vitamin D
Hormone Replacement Therapy
Bisphosphonates
Conclusion
From the Department of Medicine, University of Chicago, Chicago, Ill.
RELATED ARTICLE
December 2, 1998
JAMA. 1998;280(21):1885-1886.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Prospective Cohort Study of Soy Food Consumption and Risk of Bone Fracture Among Postmenopausal Women
Zhang et al.
Arch Intern Med 2005;165:1890-1895.
ABSTRACT
| FULL TEXT
Cancer Risk-Reduction Behaviors of Breast Cancer Survivors
Lindsey et al.
West J Nurs Res 2004;26:872-890.
ABSTRACT
|
